TP53 and cancer: Although the cancer-related TP53 mutations are determined at various positions throughout the TP53 sequence, they generally cluster within the DNA-binding domain, disrupting the ability of p53 to bind to its target DNA sequences, therefore preventing transcriptional activation of the respective genes [19].